Back

Safety and efficacy of single vs. dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation: a propensity matched analysis from the ITER registry

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Transcatheter aortic valves: the evidence is growing Aortic valve disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Matteo Bianco

San Luigi Gonzaga University Hospital, Orbassano (Italy)

8 More presentations in this session

Presentation thumbnail
Transcatheter aortic valve implantation in patients with advanced chronic kidney disease: futility or reliability?
Doctor F. Conrotto (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Multivariate Predictors for Adverse Long Term Outcome after Trancatheter Aortic Valve Implantation
Mr A. Berkowitsch (Bad Nauheim, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of transcatheter aortic valve implantation versus surgical aortic valve replacement and medical treatment: A systematic review and meta-analysis
Assistant Professor M. Noutsias (Berlin, DE)
Abstract
Presentation thumbnail
Transcatheter aortic valve implantation in high-risk patients with severely stenotic bicuspid versus tricuspid aortic valves
Presentation thumbnail
5-year follow-up after transcatheter aortic valve implantation (TAVI) in severe symptomatic aortic stenosis: results from the German TAVI registry
Professor R. Zahn (Ludwigshafen, DE)
Abstract

Access the full session

Session thumbnail
Transcatheter aortic valves: the evidence is growing

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources